In this study we have evaluated the vaccine potential of a Mycobacterium tuberculosis antigen of the PPE protein family, namely PPE44 (Rv2770c). PPE44-specific immune responses could be detected in mice acutely, chronically and latently infected with M. tuberculosis. Vaccination of mice with a plasmid DNA vaccine coding for PPE44 or recombinant PPE44 protein formulated ill adjuvant, generated strong cellular and humoral immune responses: immunodominant T cell epitopes were identified. Most importantly, vaccination of mice with both Subunit vaccines followed by an intratracheal challenge with M. tuberculosis resulted in a protective efficacy comparable to the one afforded by BCG. Taken together these results indicate that PPE44 of M. tuberculosis is a protective antigen that Could be included in novel subunit TB vaccines and that warrants further analysis, (C) 2008 Elsevier Ltd. All rights reserved.
|Autori interni:||RINDI, LAURA|
|Autori:||ROMANO M; RINDI L; KORF H; BONANNI D; ADNET P.-Y; JURION F; GARZELLI C; HUYGEN K|
|Titolo:||Immunogenicity and protective efficacy of tuberculosis subunit vaccines expressing PPE44 (Rv2770c)|
|Anno del prodotto:||2008|
|Digital Object Identifier (DOI):||10.1016/j.vaccine.2008.09.025 WC Immunology; Medicine, Research & Experimental|
|Appare nelle tipologie:||1.1 Articolo in rivista|